SAFE: a self-support eHealth intervention to support women exposed to intimate partner violence.

Completed

Conditions: depressieve stemmingsstoornissen en -afwijkingen
Intimate partner violence
10002861
10016214

Registration Number: NL-OMON46401

Lead Sponsor: Radboud Universitair Medisch Centrum

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Not specified

Target Recruitment: 88

Inclusion Criteria

Interview study: Participants will be selected by an organisation that supports female victims of IPV and will also be identified by posting messages on several websites. Participants are female victims of IPV.;RCT: Women, aged 18 years and older, self-identifying themselves as being a victim of IPV through a series of questions and consequently registering online for SAFE. Additionally, eligible women need to have access to a safe computer and/or mobile phone and Internet connection.

Exclusion Criteria

Interview study: We will exclude participants who are in acute need of care; not speaking the Dutch
language; or unable to participate in a face-to-face interview.;RCT: The upper age limit has been set at 50 for the trial because women of childbearing age bear the greatest health burden associated with DV, and are the most likely to be in relationships where IPV is present.
Women are excluded if in a follow up contact they identify that they have not been in an unhealthy or abusive relationship or experienced fear of partner in the past 6 months.
Participants not reading the Dutch language are excluded in the RCT, because content of the website (at start) and all outcome measures are in Dutch.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>We chose Self-efficacy, measured by The General Self-Efficacy Scale (GSE) as<br /><br>primary outcome measure. This scale assesses a general sense of perceived<br /><br>self-efficacy, aiming to predict coping ability and adaptation to stressful<br /><br>life events. The Scale has 10 questions with response choices on a 4-point<br /><br>scale: Not at all true/Hardly true/ Moderately true /Exactly true. The GSE has<br /><br>been validated in both the Dutch and international community (a0.78-0.94)<br /><br>[94-96]. We hypothesize that the intervention group scores a higher mean<br /><br>self-efficacy score than the comparison group, immediately after intervention<br /><br>completion and at 6 months post-baseline. The GSE will take about 5 minutes to<br /><br>complete.</p><br>

Secondary Outcome Measures